Author:
Hertlein Linda,Lenhard Miriam,Kirschenhofer Angela,Kahlert Steffen,Mayr Doris,Burges Alexander,Friese Klaus
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynaecology,General Medicine
Reference16 articles.
1. Bonomi P, Blessing JA, Stehman FB, DiSaia PJ, Walton L, Major FJ (1985) Randomized trial of three cisplatin dose schedules in squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 3(8):1079–1085
2. Rose PG, Blessing JA, Gershenson DM, McGehee R (1999) Paclitaxel and cisplatin as firstline therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 17(9):2676–2680
3. Burnett AF, Roman LD, Garcia AA, Muderspach LI, Brader KR, Morrow CP (2000) A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix. Gynecol Oncol 76(1):63–66
4. Long HJ 3rd, Bundy BN, Grendys EC Jr et al (2005) Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a gynecologic oncology group study. J Clin Oncol 23(21):4626–4633
5. Goldstein NI, Prewett M, Zuklys K, Rockwell P, Mendelsohn J (1995) Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumour xenograft model. Clin Cancer Res 1(11):1311–1318
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献